Pantodac IV Injection
Marketer
Zydus Cadila
Salt Composition
Pantoprazole (40mg)
Overview Pantodac IV Injection
Intravenous Pantoprazole (Pantodac IV Injection) is a medication that suppresses gastric acid secretion. It's indicated for treating stomach and intestinal disorders stemming from excess acid, including gastroesophageal reflux disease, peptic ulcers, and Zollinger-Ellison syndrome. This injection offers symptom relief and facilitates healing. Furthermore, it prevents stress ulcers in critically ill patients and is used pre-anesthesia to mitigate aspiration risks. Classified as a proton pump inhibitor (PPI), it's administered intravenously by medical professionals only when deemed superior to oral administration. Dosage is individualized based on your condition and response. Treatment duration is determined by your physician; consistent use as prescribed is crucial, even with rapid symptom improvement. Lifestyle modifications, such as frequent small meals and avoidance of caffeine, spicy foods, and fatty foods, enhance treatment efficacy. Common side effects include nausea, vomiting, headache, dizziness, flatulence, diarrhea, abdominal pain, and thrombophlebitis (vein inflammation). While usually mild, persistent or bothersome effects necessitate medical consultation. Prolonged use (over a year) may increase bone fracture risk, particularly at higher doses; discuss bone loss prevention strategies, such as calcium and vitamin D supplementation, with your doctor. This medication isn't suitable for everyone. Inform your doctor about severe liver disease, HIV medication use, prior allergic reactions to similar drugs, or pre-existing osteoporosis before starting treatment. Pregnant or breastfeeding individuals should seek medical advice. Alcohol consumption should be avoided due to its acid-stimulating effects. Refrain from operating machinery or driving if experiencing dizziness or drowsiness.
Uses of Pantodac IV Injection
Managing gastroesophageal reflux, peptic ulcers, and Zollinger-Ellison syndrome.
Major Benefits of Pantodac IV Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Pantodac IV Injection:
- Diarrhea
- Flatulence
- Headache
- Joint pain
- Nausea
- Stomach pain
- Vomiting
- Dizziness
- Thrombophlebitis
How to use Pantodac IV Injection:
This medication will be administered by your physician or their nursing staff; self-medication is strongly discouraged.
How Pantodac IV Injection works:
Pantoprazole intravenous injection, a proton pump inhibitor (PPI), lessens gastric acid production, thus alleviating heartburn and acid indigestion.
SAFETY ADVICE
AlcoholUNSAFE
Pantodac IV Injection should not be used concurrently with alcohol consumption.
PregnancyCONSULT YOUR DOCTOR
Administering Pantodac IV Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescription. Patient consultation with their doctor is advised.
Breast feedingSAFE IF PRESCRIBED
Intravenous Pantodac administration during lactation is likely safe. Available human data indicate minimal risk to the infant.
DrivingCONSULT YOUR DOCTOR
Pantodac IV Injection's impact on driving ability is undetermined. Refrain from driving if experiencing symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
Intravenous Pantodac administration is considered safe for patients exhibiting renal impairment. No alteration of the Pantodac IV Injection dosage is advised.
LiverCAUTION
Intravenous Pantodac administration requires careful consideration in individuals with advanced hepatic impairment. Dosage modification for Pantodac IV Injection may be necessary. Physician consultation is recommended.
What if you forget to take Pantodac IV Injection :
Omit a Pantodac IV Injection dose? Seek your physician's advice.
Facts to Know About Pantodac IV Injection
| Label | Value |
|---|---|
| Chemical Category | Benzimidazole Sulfoxide |
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
| Behavioral Class | Gastric acid suppressants |








